The injection market is currently dominated by pen injectors for insulin delivery, but autoinjectors are becoming more common and in a broader range of indications. Each device type has pros and cons. Pen injectors allow the patient to adjust the delivered dose, critical for drugs such as insulin-requiring titration. Also, pen injectors enable multiple injections from the same drug container, reducing the cost per dose.
Digital Journal: Drug Development & Delivery
Authors: Iain Simpson, Director of Business Development, Phillips Medisize and Henrick Leisner, Envoi Platform Manager, Phillips Medisize
September, 2024
Pages 43-44